Expression of cell survival/death genes: Bcl-2 and Bax at the rate of colon cancer prognosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1741, Issue 1-2, 2005, Pages 25-29

  Paul Samojedny, Monika ^a   Kokocińska, Danuta ^a   Samojedny, Arkadiusz ^a   Mazurek, Urszula ^a   Partyka, Robert ^a   Lorenz, Zbigniew ^a   Wilczok, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Apoptosis and proliferation; Bax gene; Bcl 2 gene; Colon cancer prognosis; Quantitative mRNA analysis

Indexed keywords

MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL DEATH; CELL SURVIVAL; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NICK END LABELING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATOR GENE; RNA ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL SURVIVAL; COLON; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA; RNA, MESSENGER;

EID: 20444485848     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.11.021     Document Type: Article

References (14)

1. S.R. Denmeade, and J.T. Isaacs Programmed cell death (Apoptosis) and cancer chemotherapy Cancer Control J. 3 4 1996 647 656
2. J.C. Reed Mechanisms of apoptosis Am. J. Pathol. 157 5 2000 1415 1426
3. S. Cory, and J.M. Adams The Bcl 2 family: regulators of the cellular life-or-death switch Nat. Rev., Cancer 2 9 2002 647 656
4. T. Kobayashi, H. Sawa, J. Morikawa, W. Zhang, and H. Shiku Bax induction activates apoptotic cascade via mitochondria cytochrome c release and Bax of the expression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells Jpn. J. Cancer Res. 91 12 2000 1264 1268
5. S.H. Meterissian, M. Kontogiannea, M. Al-Sowaidi, A. Linjawi, F. Halwani, B. Jamison, and M. Edwardes Bcl-is a useful prognostic marker in Duke's B colon cancer Ann. Surg. Oncol. 8 6 2001 533 537
6. H. Yamaguchi, K. Bhalla, and H. Wang Bax place a pivotal role in Thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria Cancer Res. 63 2003 1483 1489
7. S. Evertsson, Z. Bartik, H. Zhang, A. Jansson, and X.F. Sun Apoptosis in relation to proliferating cell nuclear antigen and Duke's stage in colorectal adenocarcinoma Int. J. Oncol. 15 1 1999 53 58
8. W. Huang, and X. Yao Prognostic relevance of Fas ligand in human colorectal cancer Eur. J. Gastroenterol. Hepatol. 15 4 2003 375 380
9. D.T. Leahy, H.E. Mulcahy, D.P. O'Donoghue, and N. Parfrey Bcl 2 protein expression is associated with better prognosis in colorectal cancer Int. J. Oncol. 15 1 1999 53 58
10. N. Hawkins, J. Lees, R. Hargrave, T. O'Connor, A. Meagher, and R. Ward Pathological and genetic correlates of apoptosis in the progression of colorectal neoplasia Tumour Biol. 18 3 1997 146 156
11. Z.N. Oltavi, C.L. Milliman, and S.J. Korsmeyer Bcl- 2 heterodimerizes in vitro with a conserved homolog, Bax accelerates program cell death Cell 741 1993 609 619
12. L and Bcl -2 displaces Bax and promote cell death Cell 80 1995 285 291
13. C. Doglioni, A.P. Dei Tos, L. Laurino, C. Chiarelli, M. Barbareschi, and G. Viale The prevalence of Bcl-2 immunoreactivity in breast carcinomas and clinicopathological correlates with particular reference to estrogen receptor status Virchows Arch. 424 1994 47 51
14. R.D. Leek, L. Kaklamanis, F. Pezzella, K.C. Gatter, and A.L. Harris Bcl-2 in normal human breast carcinoma association with estrogen receptor-positive, epidermal growth factor receptor-negative tumours and in-situ cancer Br. J. Cancer 69 1994 135 139